MOTS-c Aging Metabolism Research: Type Comparison
High-fat diet rodent model AMPK activation, insulin sensitivity restoration Fasting glucose reduction, glucose tolerance improvement, hepatic fat accumulation 4–8 weeks Gold standard for mechanistic studies. Allows controlled diet, genotype manipulation, and t
This comparison does not assign a generated winner or score.
- High-fat diet rodent model
- AMPK activation, insulin sensitivity restoration
- Fasting glucose reduction, glucose tolerance improvement, hepatic fat accumulation
- 4–8 weeks
- Gold standard for mechanistic studies. Allows controlled diet, genotype manipulation, and tissue-level analysis
- Aged rodent model (18–24 months)
- Mitochondrial biogenesis, age-related metabolic decline reversal
- Running endurance, muscle mitochondrial density, glucose clearance
- 6–12 weeks
- Best model for translating aging-specific effects. Captures sarcopenia, insulin resistance, and mitochondrial dysfunction
- Human observational cohort
- Endogenous MOTS-c correlation with metabolic health markers
- HbA1c, HOMA-IR, metabolic syndrome prevalence
- Cross-sectional (no intervention)
- Establishes clinical relevance but can't prove causation. Useful for identifying therapeutic targets
- In vitro muscle cell culture
- Nuclear translocation, gene expression regulation
- GLUT4 expression, glucose uptake rate, mitochondrial respiration
- 24–72 hours
- Fastest readout for dose-response and mechanism validation. Limited by lack of systemic metabolic context